One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-137118
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 6 |
Affiliation: Dana-Farber Cancer Institute, Harvard University, Centre Hospitalier Universitaire de Poitiers, Nantes Université, French National Centre for Scientific Research, University of Angers, Inserm, Centre Hospitalier Universitaire de Nantes, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Rush University Medical Center, University of Bologna, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Institut Català d'Oncologia, Oncopeptides (Sweden), University of Florida, Baptist Cancer Center, University of Pittsburgh, Oncology Institute of Hope and Innovation, Hospital Universitario Quirónsalud Madrid, Memorial Sloan Kettering Cancer Center, Baylor Medical Center at Garland, Instituto de Investigación Biomédica de Salamanca, Clinica Universidad de Navarra, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Clínic de BarcelonaHORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in 55 Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD)-Subgroup Analysis
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
